MedTrace Logo

Genepro Generation 3 Protein Bioavailability Compared to Whey Protein

NCT04615858 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-11-10

No results posted yet for this study

Summary

Objective of Clinical Trial: To test, in a blinded study the bioavailability of Genepro Generation 3 (GEN3) Protein as compared to whey protein. This study is intended to show the equivalent value of Genepro Gen3 as compared to whey protein (1scoop (12g) Genepro Generation 3 (GEN3) compared to 30g serving of whey protein). Total Serum Protein levels will be tested every other week to evaluate blood protein levels in each participant

Conditions

  • Absorption; Disorder, Protein
  • Protein Malabsorption
  • Protein Intolerance

Interventions

DIETARY_SUPPLEMENT

Genepro Generation 3 Protein

Generation 3 Genepro Protein. Micronized protein. Zero lactose. No gluten. All Natural. No flavor. No Sugar. FODMAP Certified protein. 11g in weight, scoop.

DIETARY_SUPPLEMENT

Whey Protein

Nutrition industries number 1 selling whey protein powder. No flavor. Gluten Free. 30g scoop.

Sponsors & Collaborators

  • WakeMed Bariatric Surgery & Weight Loss Center

    collaborator UNKNOWN

  • Musclegen Research, Inc.

    lead OTHER

Principal Investigators

  • Marina Maddaloni · WakeMed Bariatric Surgery Center

  • Zac Cain · Genepro Protein, Inc.

  • Brian Parks, PHD · Genepro Protein, Inc.

  • John Bruce, MD · WakeMed Bariatric Surgery Center

  • LaMonica Daniel · WakeMed Health & Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-01-26
Completion
2021-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615858 on ClinicalTrials.gov